Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Ipilimumab

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    ECOGMELS1404

    12/01/2015

    A Phase III Randomized Trial Comparing High Dose Interferon to MK-3475 (Pembrolizumab) in Patients with High Risk Resected Melanoma

    Treatment

    ECOGTHOS1400

    04/02/2015

    Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer


    Print this page for your doctor